BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36788091)

  • 1. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
    Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
    Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma.
    Hung YP; Fletcher CDM
    Am J Surg Pathol; 2017 Aug; 41(8):1034-1044. PubMed ID: 28505006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent SRF-RELA Fusions Define a Novel Subset of Cellular Myofibroma/Myopericytoma: A Potential Diagnostic Pitfall With Sarcomas With Myogenic Differentiation.
    Antonescu CR; Sung YS; Zhang L; Agaram NP; Fletcher CD
    Am J Surg Pathol; 2017 May; 41(5):677-684. PubMed ID: 28248815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
    Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
    Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.
    Agaimy A; Bieg M; Michal M; Geddert H; Märkl B; Seitz J; Moskalev EA; Schlesner M; Metzler M; Hartmann A; Wiemann S; Michal M; Mentzel T; Haller F
    Am J Surg Pathol; 2017 Feb; 41(2):195-203. PubMed ID: 27776010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV51-associated Leiomyosarcoma: A Novel Class of TP53/RB1-Wildtype Tumor With Predilection for the Female Lower Reproductive Tract.
    Williams EA; Montesion M; Lincoln V; Tse JY; Hiemenz MC; Mata DA; Shah BB; Shoroye A; Alexander BM; Werth AJ; Foley-Peres K; Milante RR; Ross JS; Ramkissoon SH; Williams KJ; Adhikari LJ; Zuna RE; LeBoit PE; Lin DI; Elvin JA
    Am J Surg Pathol; 2022 Jun; 46(6):729-741. PubMed ID: 35034043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
    Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
    Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
    Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myofibroma/myofibromatosis: a clinicopathologic analysis of 9 cases].
    Fu Y; Guan WY; Wu HY; Wu HY; Fan ZW; Ye Q; Meng FQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):45-50. PubMed ID: 29325250
    [No Abstract]   [Full Text] [Related]  

  • 16. Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature.
    Al Qawahmed R; Sawyer SL; Vassilyadi M; Qin W; Boycott KM; Michaud J
    Pediatr Dev Pathol; 2019; 22(3):258-264. PubMed ID: 30103666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors.
    Iwamura R; Komatsu K; Kusano M; Kubo C; Inaba Y; Shiba E; Nawata A; Tajiri R; Matsuyama A; Matoba H; Koga K; Takeda M; Itami H; Hisaoka M
    Mod Pathol; 2023 Mar; 36(3):100070. PubMed ID: 36788105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Distinctive Genomic and Immunohistochemical Profile for NOTCH3 and PDGFRB in Myofibroma With Diagnostic and Therapeutic Implications.
    Koo SC; Janeway KA; Harris MH; Fryer CJ; Aster JC; Al-Ibraheemi A; Church AJ
    Int J Surg Pathol; 2020 Apr; 28(2):128-137. PubMed ID: 31566039
    [No Abstract]   [Full Text] [Related]  

  • 19. Odontogenic myxomas lack PDGFRB mutations reported in myofibromas.
    de Siqueira EC; de Sousa SF; Carlos R; de Andrade BAB; Romañach MJ; Gomez RS; Gomes CC
    J Oral Pathol Med; 2020 Mar; 49(3):278-283. PubMed ID: 32050038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.